Overview

A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
To evaluate and to compare efficacy and safety of MR4 versus Prograf in patients undergoing primary liver transplantation.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Korea, Inc.
Treatments:
Tacrolimus